StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3058% above fair value
$7.05−0.23 (-3.16%)

Close on Nov 17, 2026Market cap $194.59MP/E –Yield –

Precision BioSciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Precision BioSciences's price to sales ratio was 5.4× on Nov 11, 2026, against 94.2× a year earlier. Over the last 5 years it ranged from 0.4× to 94.2×, with a median of 2.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.4×−66.6
2025Dec 31, 202572.0×+71.6
2024Dec 31, 20240.4×−0.4
2023Dec 29, 20230.8×−5.5
2022Dec 30, 20226.3×+2.6
2021Dec 31, 20213.8×−16.2
2020Dec 31, 202019.9×−14.1
2019Dec 31, 201934.1×–

More Precision BioSciences figures

See a number that looks wrong?